Back to company

MedArt ApS: Financial statements 2023

CVR: 41925736

MedArt ApS (CVR 41925736) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,404,111 and a net result of DKK 20,471 compared with DKK 11,768 the year before. That is a decrease of 5.7% compared with the year before. Equity amounted to DKK 1,238,420. The solvency ratio was 58.1%. The company had 5 employees in the financial year.

Gross Profit
2,404,111 kr.
Profit/Loss
20,471 kr.
Equity
1,238,420 kr.
Total Assets
2,131,658 kr.
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-2.4 mio.20 t.1.2 mio.5
2022-2.5 mio.12 t.1.2 mio.5
2021-2.2 mio.167 t.1.2 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2023

MedArt ApS: The 2022 annual report is outJun 21, 2023

MedArt ApS has published its annual report for 2022. Gross profit came to DKK 2,548,432, and the net result was DKK 11,768.

About MedArt ApS

MedArt ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2020. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Ole Stoklund. The company is owned by ADVALIGHT ApS. In 2024, the company reported a gross profit of DKK 2,193,702 and a net result of DKK -3,326 compared with DKK 20,471 the year before. Equity amounted to DKK 1,235,094.

Other financial years